Anti-Human TNFA Recombinant Antibody(Certolizumab)

Product Information

Catalog Number	YR1612
Product Name	Anti-Human TNFA Recombinant Antibody(Certolizumab)
Molecular Name	Certolizumab
Alias	Anti-TNFA Recombinant Antibody, Research Grade Certolizumab
Molecular Weight	150 kDa
Target	TNFA[Homo sapiens]
Isotype	Fab-IgG1
Clonity	Monoclonal
Host	Mouse
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Certolizumab pegol, sold under the brand name Cimzia, is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) and is manufactured by UCB.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price